UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number 001-40848
GUARDFORCE AI CO., LIMITED
(Translation of registrant’s name into English)
10 Anson Road, #28-01 International Plaza
Singapore 079903
(Address of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F
☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Entry into a Material Definitive Agreement
On May 2, 2023, Guardforce AI Co., Limited (the
“Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with EF Hutton,
division of Benchmark Investments, LLC, as the representative (the “Representative”) for the underwriters listed on
Schedule 1 thereto (the “Underwriters”), relating to the underwritten public offering (the “Offering”)
of 1,720,430 ordinary shares, par value $0.12 per share (the “Ordinary Shares”) of the Company (the “Offered
Securities”), at a public offering price of $4.65 per share, for aggregate gross proceeds of approximately $8.0 million, prior
to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option
to purchase up to an additional 258,064 Ordinary Shares at the public offering price per share, less the underwriting discounts to cover
over-allotments, if any. EF Hutton, division of Benchmark Investments, LLC, is acting as the lead book-running manager for the Offering.
Spartan Capital Securities, LLC is acting as the co-manager for the Offering.
On May 4, 2023, the Representative exercised the over-allotment
option in full to purchase an additional 258,064 Ordinary Shares at $4.65 per share (the “Over-Allotment Shares”) for
total gross proceeds of approximately $1.2 million before deducting underwriting discounts and offering expenses.
The Offering was closed on May 5, 2023. The Company
delivered the Offered Securities and Over-Allotment Shares (together, the “Shares”) to the Representative on the same
day.
The Shares were offered under the Company’s
registration statement on Form F-3 (File No. 333-261881), initially filed with the U.S. Securities and Exchange Commission on December
23, 2021, and was declared effective on January 5, 2022 (the “Registration Statement”). A prospectus supplement to
the Registration Statement in connection with the Offering was filed with the U.S. Securities and Exchange Commission on May 4, 2023.
The aggregate gross proceeds of the Offering, including
the over-allotment, are approximately $9.2 million, prior to deducting underwriting discounts and other Offering expenses. The Company
intends to use the net cash proceeds from the Offering for research and development to further advance AI and robotic business and technology
capabilities; business development, including sales, marketing, and business expansion; corporate management, talent recruitment and general
working capital purposes.
Pursuant to the Underwriting Agreement, the Company
agreed to pay the Underwriters a cash fee equal to 7.0% of the gross proceeds of the Offering, an additional cash fee equal to 0.5% of
the gross proceeds raised by the Company in the Offering for non-accountable expenses, and also agreed to pay the expenses of the underwriters
in connection with the Offering, including filing fees and investor presentation expenses, as well as underwriters’ counsel legal
fees, up to an aggregate of $100,000.
The Company, as well as our officers and directors,
and certain 5% shareholders, have agreed, subject to limited exceptions, for a period of 180 days after the closing of this Offering,
not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of, directly or indirectly
any Ordinary Shares or any securities convertible into or exchangeable for our Ordinary Shares either owned as of the date of the Underwriting
Agreement or thereafter acquired without the prior written consent of the Representative, subject to certain exceptions. The Representative
may, in their sole discretion and at any time or from time to time before the termination of the lock-up period, without notice, release
all or any portion of the securities subject to lock-up agreements.
As of the date of this report, we have 2,013,759
warrants issued and outstanding, which include: (i) 1,233,023 warrants to purchase 30,825 ordinary shares, subject to rounding of fractional
warrants and these warrants are exercisable at an exercise price of $6.40 per share with the expiration date of September 28, 2026; (ii)
600,013 warrants to purchase 15,000 ordinary shares, subject to rounding of fractional warrants, at an exercise price of $7.20 per share
with the expiration date of January 20, 2027 (the “Private Warrants”); and (iii) 180,723 warrants to purchase 4,518
ordinary shares, subject to rounding of fractional warrants, that were issued to the assignee of the representative of the underwriters
in our initial public offering with the expiration date of September 28, 2026 (together with (i), the “Public Warrants”).
The Public Warrants and the Private Warrants contain an antidilution provision. As a result of the Offering, the exercise price of the
Company’s Public Warrants and Private Warrants is being adjusted to $4.65 pursuant to the antidilution provisions of both warrants.
The Company has sent the notices to warrant holders regarding the adjustment of exercise price on May 5, 2023.
The foregoing description of the Underwriting
Agreement and the form of lock-up agreement does not purport to be complete and is qualified in its entirety by reference to the full
text of the Underwriting Agreement (with the lock-up agreement included as Exhibit A), a copy of which is attached hereto as Exhibit 1.1
and is incorporated herein by reference. A copy of the opinion of Conyers Dill & Pearman, as special counsel in the Cayman Islands
to the Company, regarding the legality of the issuance and sale of Shares is attached hereto as Exhibit 5.1.
The Company issued press releases on May 2, 2023
in connection with the pricing of the Offering, and on May 5, 2023 in connection with the closing of the Offering. Copy of all press releases
are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, and are incorporated herein by reference.
This report shall not constitute an offer to sell
or the solicitation to buy nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
This report on Form 6-K is incorporated by reference
into (i) the prospectus contained in the Company’s registration statement on Form F-3 (SEC File No. 333-261881) declared effective
by the Securities and Exchange Commission (the “Commission”) on January 5, 2022; (ii) the prospectus dated February 9, 2022
contained in the Company’s registration statement on Form F-3 (SEC File No. 333-262441) declared effective by the Commission on
February 9, 2022; and (iii) the prospectus contained in the Company’s Post-Effective Amendment No. 1 to Form F-1 on Form F-3 (SEC
File No. 333-258054) declared effective by the Commission on June 14, 2022.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: May 5, 2023 |
Guardforce AI Co., Limited |
| |
|
|
| |
By: |
/s/ Lei Wang |
| |
Lei Wang |
| |
Chief Executive Officer |
4
Guardforce AI (NASDAQ:GFAI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Guardforce AI (NASDAQ:GFAI)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
